SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-026576
Filing Date
2024-03-27
Accepted
2024-03-27 16:01:22
Documents
32
Period of Report
2024-03-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0202723-8k_tff.htm   iXBRL 8-K 26915
2 THE COMPANY'S INVESTOR PRESENTATION MATERIALS ea020272301ex99-1_tffpharma.htm EX-99.1 33404
3 PRESS RELEASE DATED MARCH 27, 2024 ea020272301ex99-2_tffpharma.htm EX-99.2 24221
4 GRAPHIC ex99-2_001.jpg GRAPHIC 279250
5 GRAPHIC ex99-2_002.jpg GRAPHIC 953401
6 GRAPHIC ex99-2_003.jpg GRAPHIC 259893
7 GRAPHIC ex99-2_004.jpg GRAPHIC 223683
8 GRAPHIC ex99-2_005.jpg GRAPHIC 288571
9 GRAPHIC ex99-2_006.jpg GRAPHIC 194264
10 GRAPHIC ex99-2_007.jpg GRAPHIC 213765
11 GRAPHIC ex99-2_008.jpg GRAPHIC 121205
12 GRAPHIC ex99-2_009.jpg GRAPHIC 263871
13 GRAPHIC ex99-2_010.jpg GRAPHIC 183017
14 GRAPHIC ex99-2_011.jpg GRAPHIC 232157
15 GRAPHIC ex99-2_012.jpg GRAPHIC 297488
16 GRAPHIC ex99-2_013.jpg GRAPHIC 228192
17 GRAPHIC ex99-2_014.jpg GRAPHIC 175537
18 GRAPHIC ex99-2_015.jpg GRAPHIC 208200
19 GRAPHIC ex99-2_016.jpg GRAPHIC 194788
20 GRAPHIC ex99-2_017.jpg GRAPHIC 279250
  Complete submission text file 0001213900-24-026576.txt   6608202

Data Files

Seq Description Document Type Size
21 XBRL SCHEMA FILE tffp-20240327.xsd EX-101.SCH 3018
22 XBRL LABEL FILE tffp-20240327_lab.xml EX-101.LAB 34240
23 XBRL PRESENTATION FILE tffp-20240327_pre.xml EX-101.PRE 22361
35 EXTRACTED XBRL INSTANCE DOCUMENT ea0202723-8k_tff_htm.xml XML 3728
Mailing Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746
Business Address 2600 VIA FORTUNA, SUITE 360 AUSTIN TX 78746 737-802-1973
TFF Pharmaceuticals, Inc. (Filer) CIK: 0001733413 (see all company filings)

IRS No.: 824344737 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39102 | Film No.: 24790503
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)